Drug profile · INN
quadrivalent influenza vaccine (recombinant, prepared in cell culture)
SUPEMTEK TETRA (PREVIOUSLY SUPEMTEK)
quadrivalent influenza vaccine (recombinant, prepared in cell culture) (SUPEMTEK TETRA (PREVIOUSLY SUPEMTEK)) is an FDA-listed pharmaceutical active ingredient.
Drug details — quadrivalent influenza vaccine (recombinant, prepared in cell culture)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
quadrivalent influenza vaccine (recombinant, prepared in cell culture) (SUPEMTEK TETRA (PREVIOUSLY SUPEMTEK)) is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is quadrivalent influenza vaccine (recombinant, prepared in cell culture)?
quadrivalent influenza vaccine (recombinant, prepared in cell culture) (SUPEMTEK TETRA (PREVIOUSLY SUPEMTEK)) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for quadrivalent influenza vaccine (recombinant, prepared in cell culture)?
SUPEMTEK TETRA (PREVIOUSLY SUPEMTEK) is a marketed brand name for quadrivalent influenza vaccine (recombinant, prepared in cell culture). Check FDA Drugs@FDA for the current US label holder and prescribing information.